Want to know why you lost your sense of smell after a COVID-19 infection? A small new study may have the answer. The research, published Wednesday in Science Translational Medicine, Read more
Tag: Roche Holding AG
Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of early Alzheimer’s disease, failed to meet its primary endpoints. The Swiss pharma company ROG, -3.72% Read more
Roche’s vision-loss drug Vabysmo gets EU nod
Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in the European Union after successful phase-3 study data. Vabysmo (faricimab) is a treatment for age-related macular Read more
Roche backs 2022 outlook as profit climbs, boosted by diagnostics sales
Roche Holding AG said Thursday that profit for the first half of the year increased as sales grew, mainly driven by the diagnostics division. The Swiss pharmaceutical company ROG, -0.64% Read more